Chairman of the Polpharma Group Supervisory Board Jerzy Starak talks about the company’s roadmap in Kazakhstan and future exports to the EU. With 12 years of comprehensive investments in the…
Novartis’ Sandoz spinoff is right around the corner, and, to celebrate the occasion, the Swiss pharma is plotting a special stock distribution scheme. Roughly a year after disclosing plans to…